We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+13.42%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$5.64B
AUM Growth
+$903M
Cap. Flow
+$553M
Cap. Flow %
9.8%
Top 10 Hldgs %
77.39%
Holding
81
New
14
Increased
9
Reduced
27
Closed
11

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$700M
2
BEKE icon
KE Holdings
BEKE
+$189M
3
HTHT icon
Huazhu Hotels Group
HTHT
+$148M
4
BABA icon
Alibaba
BABA
+$66.3M
5
BIDU icon
Baidu
BIDU
+$57.6M

Top Sells

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$248M
2
JD icon
JD.com
JD
+$218M
3
IQ icon
iQIYI
IQ
+$82.3M
4
ONON icon
On Holding
ONON
+$49.3M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$38.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.78%
2 Healthcare 30.64%
3 Technology 12.93%
4 Real Estate 10.43%
5 Materials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$34.3B
$1.18B 20.91%
5,472,259
PDD icon
2
Pinduoduo
PDD
$122B
$808M 14.32%
10,642,847
+7,739,047
+267% +$700M
BEKE icon
3
KE Holdings
BEKE
$17.6B
$588M 10.43%
31,228,934
+10,183,069
+48% +$189M
BABA icon
4
Alibaba
BABA
$276B
$387M 6.86%
3,785,116
+662,316
+21% +$66.3M
CRM icon
5
Salesforce
CRM
$149B
$346M 6.13%
1,731,237
DASH icon
6
DoorDash
DASH
$85.2B
$283M 5.02%
4,450,700
-53,800
-1% -$3.09M
FCX icon
7
Freeport-McMoran
FCX
$88.6B
$257M 4.55%
6,274,800
LEGN icon
8
Legend Biotech
LEGN
$3.68B
$247M 4.39%
5,130,367
-6,250
-0.1% -$306K
HTHT icon
9
Huazhu Hotels Group
HTHT
$13.2B
$164M 2.92%
3,357,573
+3,050,373
+993% +$148M
JD icon
10
JD.com
JD
$42.9B
$105M 1.87%
2,397,789
-4,225,411
-64% -$218M
ONON icon
11
On Holding
ONON
$12.6B
$102M 1.81%
3,291,204
-2,177,300
-40% -$49.3M
DQ
12
Daqo New Energy
DQ
$802M
$95.4M 1.69%
2,037,000
-64,315
-3% -$2.96M
MDLZ icon
13
Mondelez International
MDLZ
$80.2B
$74.7M 1.32%
1,070,764
MSFT icon
14
Microsoft
MSFT
$2.92T
$74.1M 1.31%
256,900
+82,800
+48% +$21.1M
CTKB icon
15
Cytek Biosciences
CTKB
$576M
$70.8M 1.26%
7,703,514
-981,016
-11% -$10.6M
BBIO icon
16
BridgeBio Pharma
BBIO
$16.8B
$66M 1.17%
3,978,410
-1,208,815
-23% -$14.1M
BIDU icon
17
Baidu
BIDU
$35.6B
$61.3M 1.09%
+405,900
New +$57.6M
ENFN
18
DELISTED
Enfusion, Inc.
ENFN
$52.2M 0.93%
4,975,183
CPNG icon
19
Coupang
CPNG
$27.7B
$51.9M 0.92%
3,241,400
-134,600
-4% -$2.09M
YSG
20
Yatsen Holding
YSG
$322M
$51.7M 0.92%
6,987,840
YMM icon
21
Full Truck Alliance
YMM
$9.64B
$42.6M 0.75%
5,594,000
+1,466,900
+36% +$11.6M
UBER icon
22
Uber
UBER
$144B
$41.7M 0.74%
1,314,000
-89,600
-6% -$2.84M
VIPS icon
23
Vipshop
VIPS
$7.13B
$35M 0.62%
2,304,797
-16,684,303
-88% -$248M
PLTK icon
24
Playtika
PLTK
$1.51B
$34.8M 0.62%
3,092,000
-72,800
-2% -$731K
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$12B
$30M 0.53%
+308,693
New +$32M

Similar funds

HHLR Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, HHLR Advisors held 81 positions worth $5.64B, up 19% from $4.74B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

HHLR Advisors deployed $553M of net new capital in Q1 2023, opening 14 new positions and adding to 9 existing holdings. Its largest new stake was Baidu: 405,900 shares worth $61.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vipshop, an estimated $248M trimmed.

  • HHLR Advisors's largest Q1 2023 buy was Baidu: 405,900 shares worth $61.3M.
  • HHLR Advisors added most to Pinduoduo in Q1 2023, an estimated $700M increase.
  • HHLR Advisors's biggest Q1 2023 reduction was Vipshop, cutting an estimated $248M.
  • HHLR Advisors fully exited Invesco QQQ Trust in Q1 2023, selling an estimated $38.6M.
  • HHLR Advisors's ten largest holdings make up 77% of its $5.64B portfolio in Q1 2023.
  • HHLR Advisors opened 14 new positions and closed 11 in Q1 2023.
  • HHLR Advisors's portfolio value rose 19% quarter-over-quarter to $5.64B.

Based on HHLR Advisors's 13F filing for Q1 2023, filed 15 May 2023.